TRACON Pharmaceuticals Inc TCON
$0.03
Last Updated: Mar 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
TCON Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, TRACON Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
TRACON Pharmaceuticals Inc. Stock Analysis TCON
United States Health Care Nano Cap TRACON Pharmaceuticals Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 17 full-time employees. The company went IPO on 2015-01-30. TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The firm is focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its contract research organization (CRO) independent product development platform to partner with other life science companies to develop and commercialize products in the United States. The Company’s clinical-stage oncology product candidate is TRC102, which is a small molecule that has been studied in Phase 1 and Phase 2 trials for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors and YH001, which is a monospecific investigational cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody. TRC102 is a small molecule in clinical development to reverse resistance to specific chemotherapeutics by inhibiting DNA base excision repair (BER). Its clinical-stage product candidate, Envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma.
TRACON Pharmaceuticals Inc (TCON) Chart
Financial Metrics & Statements of TRACON Pharmaceuticals Inc (TCON)
FAQ's for TRACON Pharmaceuticals Inc (TCON)
- As of August 2026, TRACON Pharmaceuticals Inc TCON is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TRACON Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in TRACON Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of TRACON Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of TRACON Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of TRACON Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for TRACON Pharmaceuticals Inc (TCON)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
